Year archive

BioSyent Inc. — 2025 filings

All 18 regulatory filings released by BioSyent Inc. (RX) in 2025, sourced directly from the official regulator.

18 Filings

2025 Period

2025 filings (18)

Filing	Released	Lang
Material change report - English.pdf Transaction in Own Shares	2025-12-15	English
News release - English.pdf Transaction in Own Shares	2025-12-15	English
News release - English.pdf Report Publication Announcement	2025-05-08	English
Notice of meeting - English.pdf Proxy Solicitation & Information Statement	2025-04-17	English
Management information circular - English.pdf Proxy Solicitation & Information Statement	2025-04-17	English
Form of proxy - English.pdf Proxy Solicitation & Information Statement	2025-04-17	English
News release - French.pdf Regulatory Filings	2025-04-01	French
News release - English.pdf Regulatory Filings	2025-04-01	English
News release - English.pdf Regulatory Filings	2025-03-18	English
52-109FV1 - Certification of annual filings - CEO (E).pdf Regulatory Filings	2025-03-13	English
52-109FV1 - Certification of annual filings - CFO (E).pdf Regulatory Filings	2025-03-13	English
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).PDF Regulatory Filings	2025-03-13	English
Annual MD&A - English.pdf Management Reports	2025-03-13	English
Audited annual financial statements – English.pdf Audit Report / Information FY 2024	2025-03-13	English
News release - English.pdf Earnings Release Q4 2024	2025-03-13	English
News release - English.pdf Report Publication Announcement	2025-03-06	English
Notice of the meeting and record date - English.pdf Regulatory Filings	2025-03-03	English
News release - English.pdf Notice of Dividend Amount	2025-01-30	English